• On October 15, 2025, DuPont's board of directors approved the separation of its electronics business, Qnity, and declared a pro rata special dividend of all outstanding Qnity Common Stock to shareholders of record as of October 22, 2025, with the distribution expected on November 1, 2025.
• This move signals DuPont's commitment to refocusing its portfolio by spinning off non-core businesses, potentially reshaping its long-term business profile and financial structure.
• We'll explore how the Qnity separation and special dividend may redirect DuPont's investment narrative toward specialized growth areas.

Explore 27 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

DuPont de Nemours Investment Narrative Recap

To be a shareholder in DuPont de Nemours today, you need to believe in the company’s ability to create value as it sheds non-core segments and sharpens its focus on specialized growth markets such as healthcare and water. The announced Qnity electronics business separation and special stock dividend represent the biggest catalyst for a re-rating of DuPont’s long-term business profile, but these changes also magnify exposure to operational volatility, making DuPont’s earnings mix less predictable in the short term.

One product launch stands out in the context of this shift: DuPont’s worldwide introduction of the IntegraTec XTP 100 IG ultrafiltration modules, which underscores management’s emphasis on innovation in its core water technology segment. This push for product advancement aligns with DuPont’s stated intent to generate sustainable growth and higher margins, even as the company’s portfolio becomes more concentrated after the Qnity spin-off and recent divestitures.

By contrast, investors should be aware that ongoing legal liabilities tied to environmental issues, particularly PFAS-related litigation, could still pressure free cash flow and net earnings over time...

DuPont de Nemours' outlook anticipates $14.0 billion in revenue and $1.7 billion in earnings by 2028. This reflects an expected 3.7% annual revenue growth and a substantial earnings increase of $1.63 billion from the current $71.0 million.

Uncover how DuPont de Nemours' forecasts yield a $93.81 fair value, a 16% upside to its current price.

Exploring Other Perspectives

Four independent fair value estimates from the Simply Wall St Community span US$93.81 to US$131.82 per share. As the Qnity spin-out alters DuPont’s risk-reward, these wide-ranging views remind you that opinions can vary greatly, consider exploring diverse forecasts and risk factors.

Explore 4 other fair value estimates on DuPont de Nemours - why the stock might be worth as much as 62% more than the current price!

Build Your Own DuPont de Nemours Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your DuPont de Nemours research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free DuPont de Nemours research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate DuPont de Nemours' overall financial health at a glance.

Searching For A Fresh Perspective?

Our top stock finds are flying under the radar-for now. Get in early:

• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 24 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.